Evelo Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EVLO and buy or sell other stocks, ETFs, and their options commission-free!About EVLO
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology.
CEOBalkrishan Gill
CEOBalkrishan Gill
Employees66
Employees66
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees66
Employees66
EVLO Key Statistics
Market cap22.81K
Market cap22.81K
Price-Earnings ratio-3.13
Price-Earnings ratio-3.13
Dividend yield—
Dividend yield—
Average volume43.16M
Average volume43.16M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.29
52 Week high$3.29
52 Week low$0.0243
52 Week low$0.0243
Stock Snapshot
The current Evelo Biosciences(EVLO) stock price is $0.00, with a market capitalization of 22.81K. The stock trades at a price-to-earnings (P/E) ratio of -3.13.
On 2025-12-06, Evelo Biosciences(EVLO) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 43.16M.
The stock's 52-week range extends from a low of $0.02 to a high of $3.29.
The stock's 52-week range extends from a low of $0.02 to a high of $3.29.
People also own
Based on the portfolios of people who own EVLO. This list is generated using Robinhood data, and it’s not a recommendation.